Latest Biomaterials News

ETEX Corporation to present at the 9th World Biomaterial CongressCAMBRIDGE, Mass., May 22, 2012 /PRNewswire/ -- ETEX Corporation, an advanced biomaterials company, today announced two presentations at the upcoming 9th World Biomaterial Congress, June 1-5, 2012 in Chengdu, China. ETEX will highlight their vertebral augmentation and cell carrier development programs. Dr. Jerry Chang, Head of R&D of ETEX Corporation, will deliver an oral presentation ent...

IntelliCell BioSciences Announces Collaborative Agreement with the University of Florida on Stem Cell and Tissue Repair ResearchNEW YORK, May 22, 2012 /PRNewswire/ -- IntelliCell BioSciences, Inc. ("Company") (OTCQB: SVFC.PK) announced today that it has entered a sponsored research agreement with the Institute for Cell Engineering and Regenerative Medicine (ICERM) at the University of Florida. A portion of the collaborative work will be to explore the physiological characteristics o...

Heraeus Celebrates Expanded Facebook PresenceSOUTH BEND, Ind., May 21, 2012 /PRNewswire/ -- Heraeus Kulzer, LLC, the worldwide leader in dental esthetics, recently expanded its presence on Facebook in order to better support its customers. Visitors who "like" the company's page between now and June 30, 2012 will be entered in a drawing for one of 60 Venus Diamond composite kits featuring either syringes or PLTs (pre-loaded tips).&...

The Hartwell Foundation Recognizes the University of Michigan as a Top Ten Center of Biomedical ResearchThe Hartwell Foundation Recognizes the University of Michigan as a Top Ten Center of Biomedical Research Awards the University a Hartwell Fellowship ANN ARBOR, Mich., May 21, 2012 /PRNewswire-USNewswire/ -- The Hartwell Foundation has again named the University of Michigan (U-M) a Top Ten Center of Biomedical Research, having recognized the U-M in this way every year since 2006. Recog...

Regentis Biomaterials completes venture financing

Scientist develops cutting edge medical-setting waiting room for childrenElaine Biddiss, Professor at the University of Toronto's Institute of Biomaterials and Biomedical Engineering (IBBME) and Scientist at the Holland Bloorview Research Institute, has developed a cutting edge medical-setting waiting room for children.

Mary Ann Liebert releases BioResearch Open Access journalThe inaugural issue of BioResearch Open Access, a new bimonthly peer-reviewed open access journal, was released today by Mary Ann Liebert, Inc., publishers. The Journal provides a new rapid-publication forum for a broad range of scientific topics inc...

Introducing Screenplay: An interactive children's waiting room experience(University of Toronto) Elaine Biddiss, professor at the University of Toronto's Institute of Biomaterials and Biomedical Engineering and scientist at the Holland Bloorview Research Institute, has developed a cutting edge medical-setting waiting room...

Biomaterials: High-voltage plant proteinsCrystals of photosynthetic protein complexes extracted from plant cells can generate extraordinarily high voltages when placed on a conducting surface and stimulated by light.Each of the light-transducing complexes known as photosystem I can generate...

Verdezyne Names Ray W. Miller as Chief Business OfficerVerdezyne, Inc., a privately-held industrial biotechnology company focused on producing renewable chemicals from non-petroleum sources, announced the appointment of Ray W. Miller as Chief Business Officer. Mr. Miller will head up Verdezyne’s business development initiatives. Verdezyne, Inc., today announced the appointment of Ray W. Miller as Chief Busines...

Hygienist Kristine Hodsdon, RDH to Be a Contributor to "Heraeus Dental 360" e-NewsletterSOUTH BEND, Ind., May 16, 2012 /PRNewswire/ -- Heraeus Kulzer, LLC, the worldwide leader in dental esthetics, announced today that Kristine Hodsdon, RDH, BS will be a regular contributor to its "Heraeus Dental 360" e-newsletter. Ms. Hodsdon is the Director of RDH eVillage, Pennwell Publishing's e-newsletter for dental hygiene professionals. She is also founder and president of Dental I...

Frost & Sullivan Forecasts that Advanced Products and Technologies will Find High Uptake in the U.S. Tissue Engineering MarketMOUNTAIN VIEW, Calif., May 16, 2012 /PRNewswire/ -- Tissue engineering has the ability to hasten the treatment of wounds and other conditions. This procedure's rising popularity as an alternative to tissue or organ transplantation has sparked off a spate of technology and product advancements in various segments of the market. New analysis from Frost & Sullivan's (http://www.med...

The Ventyx Wesley Research Institute Tissue Bank Joins the BioServe Network BELTSVILLE, MD -- (Marketwire) -- 05/16/12 -- BioServe today announced that the Ventyx Wesley Research Institute Tissue Bank, the largest state-of-the-art bio-repository of human tissue and blood in Queensland, Australia, has joined BioServe's network of affiliated bio-repositories. As part of the BioServe Network, the Ventyx Wesley Research Institute Tissue Bank will make available its high vol...

Heraeus' Venus Diamond® Helps Clinicians Work Everyday MiraclesSOUTH BEND, Ind., May 15, 2012 /PRNewswire/ -- Heraeus Kulzer, LLC, the worldwide leader in dental esthetics, recently launched a new initiative entitled TLC: Transforming Lives Chronicles. The campaign involves a series of news releases about dental professionals nationwide who have used the company's materials to create a profound impact on a patient's lives. (Photo: http://ph...

aap reports profitable Q1 2012 sales growth of 51% to EUR 9.9 million; Increased sales forecast for the financial year 2012 to EUR 34 million (+16%)aap Implantate AG / aap reports profitable Q1 2012 sales growth of 51% to EUR 9.9 million; Increased sales forecast for the financial year 2012 to EUR 34 million (+16%) . Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible for the content of this announcement. aap Implantate AG, a medical technology company listed in the Frankfurt Stock Exchange's Prime Standa...

Applied DNA Sciences Reports Fiscal Second Quarter 2012 Results STONY BROOK, NY -- (Marketwire) -- 05/15/12 -- Applied DNA Sciences, Inc. (OTCBB: APDN) announced its financial results for the second fiscal quarter ending March 31, 2012, generating revenues of $518,402. This represents the company's highest recorded quarterly revenues, and is the second sequential quarter to set this record. Second Quarter Highlights: "The Company began FY '12 with an excit...

Stem cells: A view from the rootsIn both plants and animals, regeneration requires the activation of stem cells. This is possibly related to the origin and requirements of multicellularity. Although long diverged from a common ancestry, plant and animal models such as Arabidopsis, D...

Regentis raises $10 million in Series C financingRegentis Biomaterials, a privately held company of Princeton, N.J., focused on developing proprietary hydrogels for tissue regeneration, has raised $10 million in its latest round of funding.

HyStem®-C Demonstrated Effective when Formulated with Human Heart Cells and Transplanted in an Animal Model of Heart DiseaseBioTime, Inc. (NYSE MKT: BTX) announced today the publication of a scientific paper demonstrating the effectiveness of HyStem®-C in the transplantation of heart muscle-derived cells in an animal model of heart disease. The paper, “Functional performance of human cardiosphere-derived cells delivered in an in situ polymerizable hyaluronan-gelatin hydrogel...

Angel Biotech acquires collagen plant in UKAngel Biotechmology Holdings (ABH) has acquired the biomaterial and collagen manufacturing business in Glasgow, UK, for a total cash consideration of £200,000.

Regentis Biomaterials Announces $10 Million Raised in Latest Round of FundingOR AKIVA, Israel and PRINCETON, New Jersey, May 14, 2012 /PRNewswire/ -- Regentis Biomaterials Ltd., a privately held company focused on developing proprietary hydrogels for tissue regeneration, announced that it has raised $10 million in its latest round of funding from new investors Royal DSM through its venturing subsidiary and from Crossroad Fund, as well as from existing investors Medica Ven...

Heraeus and Benco Dental Team Up to Help Customers Turn Scrap into CashSOUTH BEND, Ind., May 14, 2012 /PRNewswire/ -- Heraeus Kulzer, LLC, the worldwide leader in dental esthetics, announced today that it is partnering with Benco Dental to make it more profitable and convenient for Benco customers to trade in their scrap metals for cash. Heraeus, the world's largest private precious metal refiner, and Benco, the largest privately owned, full-service dental di...

Heraeus Launches Remarkably Smooth Venus® Pearl CompositeSOUTH BEND, Ind., May 11, 2012 /PRNewswire/ -- Heraeus Kulzer, LLC, the worldwide leader in dental esthetics, today announced that it has launched a new light curing, radio-opaque nano hybrid composite - Venus® Pearl. Venus Pearl is indicated for adhesively bonded, tooth-colored restorations in the anterior and posterior regions. Due to its remarkably soft consistency, this new uni...

InVivo Therapeutics Adds Senior Leadership in Manufacturing and Cell ResearchInVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), announced today the appointment of Jack Harvey as Senior Director of Manufacturing and Celina Chang as Senior Scientist as the Company ramps up preparations for a human clinical trial and begins to expand its product portfolio to other nervous system conditions. Mr. Harvey will lead InVivo Therape...

Angel Biotechnology sets up specialist collagen arm to focus on regenerative marketBiologics manufacturer and supplier Angel Biotechnology Holdings (LON:ABH) has bought a collagen manufacturing facility in Scotland for £200,000 to boost its presence in the regenerative medicine market. Angel has also set up a new subsidiary,...

0 1 2 3 4 ›»

buy Biomaterials market research data and corporate reports now Advertisement